Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by money4golfon Feb 16, 2024 8:05pm
260 Views
Post# 35885349

BAXTER on LinkedIn

BAXTER on LinkedIn
 
According to the CDC, one in three people who die in the hospital had sepsis during their stay. Baxter's Angela Craig, Medial Science Liasion and Clinical Nurse Specialist in Critical Care, recently spoke about this issue with Repertoire Magazine.
'

“In addition to its impact on patients, sepsis is an important health focus because the condition is also a burden to healthcare systems,” said Angela Craig, Medical Science Liaison and Clinical Nurse Specialist in Critical Care, Baxter. “Sepsis is the number one cause of hospital readmissions2, sepsis patients usually have a longer hospital stay3, and sepsis is the most expensive reason for hospitalization, costing more than $53 billion annually in the U.S.4, 5
“One essential step in sepsis monitoring is to bring together relevant experts inside a hospital to provide a multi-disciplinary approach to the rapid identification and treatment of sepsis. Leadership commitment to supporting that team’s work also helps encourage implementation of the standard processes and protocols used to rapidly identify and treat patients at risk for sepsis,” said Demehin.

“Patients hospitalized with sepsis often receive IV fluids, and proper fluid management may improve a patient’s clinical outcomes. Increasing awareness among healthcare teams of early detection of the condition and appropriate fluid management tools that provide accurate and precise data such as the Starling Fluid Management Monitoring System can help make an important impact,” said Craig.

Said Craig, “At Baxter, our mission is to save and sustain lives. For sepsis, that comes to life by helping to bring awareness to the condition, early detection, and treatment including the critical role that fluid management can play.”


https://repertoiremag.com/the-dangers-of-sepsis.html

Hello buyout very soon IMHO

 

<< Previous
Bullboard Posts
Next >>